Basic Information
Revolution Medicines is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The company's R&D pipeline includes RAS(ON) inhibitors designed to inhibit various oncogenic variants of the RAS protein, as well as RAS companion inhibitors for combination treatment strategies.
Revolution Medicines, Inc.
Redwood City,California,United States of America
15~50 people
January 01, 2015
inquires@revolutionmedicines.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios